Real-world glycemic outcomes in patients with type 2 diabetes initiating exenatide once weekly and liraglutide once daily: a retrospective cohort study

William B Saunders,1 Hiep Nguyen,2 Iftekhar Kalsekar2 1Department of Public Health Sciences, College of Health and Human Services, The University of North Carolina at Charlotte, Charlotte, NC, 2AstraZeneca, Fort Washington, PA, USA Aim: The glucagon-like peptide-1 receptor agonists exenatide once we...

Full description

Saved in:
Bibliographic Details
Main Authors: Saunders WB, Nguyen H, Kalsekar I
Format: article
Language:EN
Published: Dove Medical Press 2016
Subjects:
Online Access:https://doaj.org/article/2823c33f51e4422c94a92ae44de99a39
Tags: Add Tag
No Tags, Be the first to tag this record!